Chief of Hematology and the Blood and Marrow Transplantation (BMT) and Cellular Immunotherapy P[...]

LRES Corporation; Chicago (IL); On-site; USD 159,000 - 986,000; Full time

Job summary

An established industry player is seeking a Chief of Hematology and Director of the BMT Program to lead a renowned team in advancing cellular therapy and transplantation. This role offers the opportunity to shape clinical, research, and procedural activities while collaborating with diverse departments to align with the organization's mission. The successful candidate will enjoy a competitive compensation package, ample laboratory space, and the ability to hire junior faculty, making this a unique opportunity to impact patient care and research in a leading medical institution. If you are a visionary leader with a passion for hematology and transplantation, this position is for you.

Benefits

Paid Time Off

Paid Malpractice Insurance

Relocation Expense Reimbursement

CME Days and Allowance

Excellent Benefits Package

Qualifications

• Must be BE/BC with significant leadership experience in hematology.
• Experience in managing clinical and research activities is essential.

Responsibilities

• Provide administrative leadership for the BMT Program and Cellular Immunotherapy.
• Collaborate across multiple disciplines to execute strategic plans.

Skills

Leadership

Clinical Research

Transplantation Expertise

Collaboration

Administrative Management

Education

Board Eligible/Board Certified (BE/BC)

Job description

Employment Opportunities Designed to Help Us Collaborate in Creation!

Chief of Hematology and the Blood and Marrow Transplantation (BMT) and Cellular Immunotherapy Program - Loyola University, Chicago

The Division of Hematology-Oncology at Loyola Medicine is seeking a physician leader at an Associate or Professor ranking for the Coleman Endowed Chief of Hematology and the Blood and Marrow Transplantation (BMT) and Cellular Immunotherapy Program.

The BMT Program at Loyola Medicine has long been a leader in Hematology research and therapy within the Chicagoland area and nationally with longstanding excellence of its Cellular Therapy and BMT Programs. Loyola University is a BMT - CTN core center as part of the Oregon Health and Science University consortium, and is actively involved in the development and implementation of BMT - CTN clinical trials and has been a leader of SWOG malignant Hematology and BMT studies for the past 35 years.

The BMT Program performs over 120 adult transplants per year and an increasing number of CAR -T treatments in its dedicated inpatient and outpatient space to care for patients with its multidisciplinary team of physicians, APPs, social workers, nurse coordinators, and financial counselors. The BMT Program runs the out-pt High Dose Unit with 12 day hospital beds that afford it the ability to provide day long complex treatments including out-patient transplants on a 365 day basis.

The Loyola Medicine BMT Program was the first in the state of IL to perform CAR -T and continues to be a leader in this field as the only center capable of producing CAR -Ts in-house with its cGMP core lab. The BMT Program is fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and the National Marrow Donor Program (NMDP). The center routinely performs allografts from matched related, matched unrelated, and haploidentical transplants and has been a leader in cord blood transplantation for the past twenty years.

The Chief of Hematology, and Director of the Cellular Immunotherapy and BMT Program will provide administrative leadership, management, and quality program supervision for the clinical, research, and procedural activities of this Section of the Division of Hematology-Oncology. The Chief will collaborate with leadership across multiple disciplines and departments at Loyola Medicine to execute a cohesive organizational strategy that aligns with the mission and strategic plan of Loyola Medicine. An attractive package is being offered to include ample laboratory space, start up funding and support staff for a translational Hematology/Cellular Therapy/Transplant research program with the ability to hire junior faculty will be provided to the candidate.

The Chief reports to the Division Chief of the Section of Hematology-Oncology and will work closely with the Cancer Center Director and Chair of Medicine.

For more information, visit loyolamedicine.org.

Qualifications

Minimum Education and/or Work Experience: BE/BC

Compensation and Benefits

This opportunity offers a competitive compensation and benefits package including:

• Competitive starting compensation between $159,000 – $985,945
• Salary Based on Academic Rank and Experience
• Excellent Benefits: Trinity Health Benefits Summary
• Paid Time Off Days
• Paid malpractice, including post-employment tail coverage
• Relocation Expense Reimbursement (in accordance with IRS guidelines)
• CME Days and Allowance
• Additional Benefits from LUC or VA (if applicable)

Special Instructions to Applicants

Interested candidates should email cover letter and CV to Saja Ihmoud, Physician Recruitment Office, at [e-mail] as well as apply online at www.careers.luc.edu.

About Loyola University Chicago

Founded in 1870, Loyola University Chicago is the largest of twenty-seven Jesuit colleges and universities and one of the largest Catholic universities in the United States. Loyola enrolls approximately 17,000 students, including over 11,000 undergraduates, across its three campuses in the Chicago metropolitan area.

EQUAL OPPORTUNITY EMPLOYER

Loyola University Chicago is an Equal Opportunity/Affirmative Action employer with a strong commitment to hiring for our mission and diversifying our faculty.